JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Technical Resources
OPEN ACCESS: Zhang, Wanqiu et al. (2023) SRRM2 is a target for the immunotherapy of AML with rationally designed CAR-T cells. ResearchGate.

OPEN ACCESS: Zhang, Wanqiu et al. (2023) SRRM2 is a target for the immunotherapy of AML with rationally designed CAR-T cells. ResearchGate.

We're sorry, an error has occurred while generating this content.

Categories: Publications

Tags: 91154